Gaetani et al., 1999 - Google Patents
Metalloproteases and intracranial vascular lesionsGaetani et al., 1999
- Document ID
- 3459034664323340599
- Author
- Gaetani P
- y Baena R
- Tartara F
- Luca Messina A
- Tancioni F
- Schiavo R
- Grazioli V
- Publication year
- Publication venue
- Neurological research
External Links
Snippet
Recent studies have suggested that metalloproteinases (MMP) might be involved in the pathogenesis of cerebral aneurysm formation and rupture and that elevated serum levels of MMP may effectively be considered as possible markers of cerebrovascular malformations …
- 238000007917 intracranial administration 0 title abstract description 24
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gaetani et al. | Metalloproteases and intracranial vascular lesions | |
| Gando et al. | Posttrauma coagulation and fibrinolysis | |
| Annabi et al. | Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms | |
| Hampton et al. | Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation | |
| Kim et al. | Matrix metalloproteinase-9 in cerebral aneurysms | |
| Van Veldhuizen et al. | Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip | |
| Califf et al. | Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction | |
| Haro et al. | Matrix metalloproteinase-7–dependent release of tumor necrosis factor-α in a model of herniated disc resorption | |
| Woo et al. | Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation | |
| Chen et al. | Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque | |
| Dahlen et al. | Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma | |
| Funayama et al. | Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction | |
| Krex et al. | Genesis of cerebral aneurysms–an update | |
| Van Thiel et al. | Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease | |
| Walmsley et al. | Contrasting fibrinolytic responses in Type 1 (insulin‐dependent) and Type 2 (non‐insulin‐dependent) diabetes | |
| Undas et al. | Congenital structural and functional fibrinogen disorders: a primer for internists | |
| Kassam et al. | Altered arterial homeostasis and cerebral aneurysms: a review of the literature and justification for a search of molecular biomarkers | |
| Matsuura et al. | Is factor XII deficiency related to recurrent miscarriage? | |
| Yue et al. | Alteration of plasma antithrombin III levels in ischemic heart disease | |
| Chen et al. | Hemostatic molecular markers in nephrotic syndrome | |
| Makrakis et al. | Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in plasma/serum and urine of women during term and threatened preterm labor: a clinical approach | |
| JP2012197279A (en) | USE OF FACTOR VIIa OR FACTOR VIIa EQUIVALENT FOR PREVENTING OR ATTENUATING HEMORRHAGE GROWTH AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HEMORRHAGE (ICH) | |
| Hoffman et al. | The use of proteases as prognostic markers for the healing of venous leg ulcers | |
| Miller et al. | Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII) | |
| España et al. | Complexes of activated protein C with α1-antitrypsin in normal pregnancy and in severe preeclampsia |